Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
COVID-19 Updates: COVID-19 Resources » Vaccine Update » Updated Visitor Policy » What We're Doing to Keep You Safe »
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects with Refractory Generalized Myasthenia Gravis (gMG)
Trial ID or NCT#
NCT01997229
Status
NOT RECRUITING
Purpose
The purpose of this study is to determine if eculizumab is safe and effective for the treatment of patients with refractory gMG.
Investigator(s)
Srikanth Muppidi, MD
Contact us to find out if this trial is right for you.
CONTACT
Lesly Welsh
(650) 497-3079
View on ClinicalTrials.gov
About this Clinical Trial
Your Message Will Go To
Lesly Welsh650-497-3079